BioCentury | Apr 2, 2019
Financial News

Fusion raises $105M series B for radiopharmaceutical pipeline

...Adams Street Partners, Johnson & Johnson Innovation -- JJDC Inc., TPG Biotech, Seroba Life Sciences, Genesys Capital...
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Isogenica Ltd. Number of employees: 20 Funds raised: $46 million Investors: Adams Street Partners, FACIT, Genesys Capital...
BioCentury | Sep 29, 2017
Financial News

Fusion, IsoPlexis, Tempus announce venture financings

...investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems joined existing investors FACIT, Genesys Capital...
BioCentury | Sep 25, 2017
Financial News

Venture roundup: Fusion, IsoPlexis, Tempus

...investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems joined existing investors FACIT, Genesys Capital...
BioCentury | Feb 24, 2017
Financial News

Fusion Pharmaceuticals completes venture financing

...led by existing investor Johnson & Johnson Innovation-JJDC Inc. New investors HealthCap, TPG Biotech and Genesys Capital...
BioCentury | Feb 23, 2017
Financial News

McMaster cancer spinout launches with $25M

...led by existing investor Johnson & Johnson Innovation-JJDC Inc. New investors HealthCap, TPG Biotech and Genesys Capital...
BioCentury | Aug 22, 2016
Financial News

Genesys Capital financial update

...$773,000) in Genesys Ventures III L.P., a Canadian-based life sciences venture capital fund managed by Genesys Capital. WIR...
BioCentury | Sep 21, 2015
Financial News

Aptinyx completes venture financing

...Goudy Park Capital; Portola Capital Partners; Sabby Capital; Adams Street Partners; Baxter Ventures; Druid BioVentures; Genesys Capital...
BioCentury | Dec 8, 2014
Financial News

Naurex completes venture financing

...Goudy Park Capital; Portola Capital Partners; Sabby Capital; Adams Street Partners; Baxter Ventures; Druid BioVentures; Genesys Capital...
BioCentury | Dec 4, 2014
Financial News

Naurex raises $80M in series C

...Capital; Portola Capital; and Sabby Capital. Existing investors Adams Street Partners; Baxter Ventures; Druid BioVentures; Genesys Capital...
Items per page:
1 - 10 of 53
BioCentury | Apr 2, 2019
Financial News

Fusion raises $105M series B for radiopharmaceutical pipeline

...Adams Street Partners, Johnson & Johnson Innovation -- JJDC Inc., TPG Biotech, Seroba Life Sciences, Genesys Capital...
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Isogenica Ltd. Number of employees: 20 Funds raised: $46 million Investors: Adams Street Partners, FACIT, Genesys Capital...
BioCentury | Sep 29, 2017
Financial News

Fusion, IsoPlexis, Tempus announce venture financings

...investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems joined existing investors FACIT, Genesys Capital...
BioCentury | Sep 25, 2017
Financial News

Venture roundup: Fusion, IsoPlexis, Tempus

...investors Adams Street Partners, Seroba Life Sciences and Varian Medical Systems joined existing investors FACIT, Genesys Capital...
BioCentury | Feb 24, 2017
Financial News

Fusion Pharmaceuticals completes venture financing

...led by existing investor Johnson & Johnson Innovation-JJDC Inc. New investors HealthCap, TPG Biotech and Genesys Capital...
BioCentury | Feb 23, 2017
Financial News

McMaster cancer spinout launches with $25M

...led by existing investor Johnson & Johnson Innovation-JJDC Inc. New investors HealthCap, TPG Biotech and Genesys Capital...
BioCentury | Aug 22, 2016
Financial News

Genesys Capital financial update

...$773,000) in Genesys Ventures III L.P., a Canadian-based life sciences venture capital fund managed by Genesys Capital. WIR...
BioCentury | Sep 21, 2015
Financial News

Aptinyx completes venture financing

...Goudy Park Capital; Portola Capital Partners; Sabby Capital; Adams Street Partners; Baxter Ventures; Druid BioVentures; Genesys Capital...
BioCentury | Dec 8, 2014
Financial News

Naurex completes venture financing

...Goudy Park Capital; Portola Capital Partners; Sabby Capital; Adams Street Partners; Baxter Ventures; Druid BioVentures; Genesys Capital...
BioCentury | Dec 4, 2014
Financial News

Naurex raises $80M in series C

...Capital; Portola Capital; and Sabby Capital. Existing investors Adams Street Partners; Baxter Ventures; Druid BioVentures; Genesys Capital...
Items per page:
1 - 10 of 53